Changes in the transcriptome and synthetic lethal dependencies following KRAS mutant expression reveal profound tissue specificity
Proceedings of the National Academy of Sciences · 08.09.2026 · 123 (36)
DOI: 10.1073/pnas.2614664123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 02.09.2026. Verfasst von Timothy D Martin und 3 weiteren Autor:innen. Beteiligte Einrichtung: HHMI, Department of Genetics, Harvard University Medical School, Boston, MA 02115. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Transcriptome, Mutation, Synthetic Lethal Mutations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK (CRUK), Mark Foundation For Cancer Research (MFCR), HHMI (HHMI).
Abstract (Originalsprache)
Oncogenic KRAS mutations exhibit a striking tissue-restricted tropism, occurring with high frequency in pancreatic, colorectal, and lung adenocarcinomas while remaining rare in other lineages. The molecular basis for why these specific tissues are uniquely permissive to KRAS transformation, and how this context shapes therapeutic vulnerabilities, remains poorly defined. Here, we utilized CRISPR-mediated genome engineering to generate endogenous, conditional KRAS-mutant isogenic cell line models across three primary permissive lineages (lung, colon, and pancreas) and the nonpermissive breast lineage. Integrated genome-wide CRISPR fitness screens and comparative transcriptome analyses revealed that KRAS-driven synthetic lethal (SL) dependencies are profoundly shaped by their tissue of origin. Strikingly, we observed minimal overlap in SL hits across lineages, with only three genes shared among the permissive lines, suggesting that the KRAS oncogene operates through divergent, context-specific genetic networks. Mechanistically, we show that KRAS activation induces a universal MYC-driven metabolic signature, but the specific machinery required to sustain this state is lineage-restricted. We identified a dependency on the diphthamide synthesis pathway to maintain translational fidelity amid a KRAS-induced hypertranslational state. These findings demonstrate that even when driven by the same oncogene, tumors exhibit distinct regulatory landscapes and unique genetic vulnerabilities. Our results provide a framework for developing lineage-aware therapeutic strategies, moving beyond universal KRAS inhibition toward targeted interventions tailored to a tumor’s specific tissue context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HHMI, Department of Genetics, Harvard University Medical School, Boston, MA 02115.
- Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115.
- Program in Virology, Harvard University Medical School, Boston, MA 02115.
ORCID-Profile: Timothy D Martin, Julia C McBride, Stephen J Elledge
Förderung
- Cancer Research UK (CRUK)
- Mark Foundation For Cancer Research (MFCR)
- HHMI (HHMI)
- Ludwig Family Foundation (The Ludwig Family Foundation)
Zitieren
APA
Martin, T. D., Choi, M. Y., McBride, J. C., & Elledge, S. J. (2026). Changes in the transcriptome and synthetic lethal dependencies following KRAS mutant expression reveal profound tissue specificity. Proceedings of the National Academy of Sciences, 123(36). https://doi.org/10.1073/pnas.2614664123
Vancouver
Martin TD, Choi MY, McBride JC, Elledge SJ. Changes in the transcriptome and synthetic lethal dependencies following KRAS mutant expression reveal profound tissue specificity. Proceedings of the National Academy of Sciences. 2026;123(36). doi:10.1073/pnas.2614664123
BibTeX
@article{Martin2026,
author = {Martin, Timothy D and Choi, Mei Yuk and McBride, Julia C and Elledge, Stephen J},
title = {Changes in the transcriptome and synthetic lethal dependencies following KRAS mutant expression reveal profound tissue specificity},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {36},
doi = {10.1073/pnas.2614664123}
}
EUVIMED